(Photo by Kirk Mckoy/Los Angeles Times via Getty Images) When it comes to surgical innovation, Intuitive Surgical (NASDAQ: ISRG) often dominates investor attention. But Insulet Corporation (NASDAQ: ...

Insulet Corporation (NASDAQ:PODD) is one of the most oversold healthcare stocks to invest in. Insulet Corporation (NASDAQ:PODD) received a rating update from Truist on April 15. The firm cut the price ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Insulet Corporation is one of them. Insulet Corporation (NASDAQ:PODD) is a global leader in tubeless insulin ...

To Read the Recap, Click Here. PODD convened 1,000 senior drug delivery executives from pharmaceutical, biotech, medical device, and across all areas of drug delivery focused on developing more ...

INSULET ($PODD) posted quarterly earnings results on Thursday, May 8th. The company reported earnings of $1.02 per share, beating estimates of $0.82 by $0.20. The ...

Investors in Insulet Corp (Symbol: PODD) saw new options begin trading this week, for the April 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PODD ...

View Insulet Corporation PODD stock quote prices, financial information, real-time forecasts, and company news from CNN.

The PODD: Partnership Opportunities in Drug Delivery conference announced the keynotes for its 15th annual conference which takes place on October 27-28 at the Westin Copley Place in Boston, MA. “In ...

Insulet delivers strong fundamentals, with robust revenue growth, high margins, and impressive returns on capital, driven by Omnipod's success. PODD's Q3 results were strong, featuring record revenues ...

Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q1 CY2026 results , with sales up 33.9% year on year to $761.7 million. On the other hand, next quarter’s revenue guidance of $785.4 ...